Literature DB >> 19593474

Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis.

Karthik Raman1, Rohit Vashisht, Nagasuma Chandra.   

Abstract

Tuberculosis continues to be a major health challenge, warranting the need for newer strategies for therapeutic intervention and newer approaches to discover them. Here, we report the identification of efficient metabolism disruption strategies by analysis of a reactome network. Protein-protein dependencies at a genome scale are derived from the curated metabolic network, from which insights into the nature and extent of inter-protein and inter-pathway dependencies have been obtained. A functional distance matrix and a subsequent nearness index derived from this information, helps in understanding how the influence of a given protein can pervade to the metabolic network. Thus, the nearness index can be viewed as a metabolic disruptability index, which suggests possible strategies for achieving maximal metabolic disruption by inhibition of the least number of proteins. A greedy approach has been used to identify the most influential singleton, and its combination with the other most pervasive proteins to obtain highly influential pairs, triplets and quadruplets. The effect of deletion of these combinations on cellular metabolism has been studied by flux balance analysis. An obvious outcome of this study is a rational identification of drug targets, to efficiently bring down mycobacterial metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593474     DOI: 10.1039/B905817F

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  12 in total

1.  Computational models for neglected diseases: gaps and opportunities.

Authors:  Elizabeth L Ponder; Joel S Freundlich; Malabika Sarker; Sean Ekins
Journal:  Pharm Res       Date:  2013-08-30       Impact factor: 4.200

2.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0.

Authors:  Jan Schellenberger; Richard Que; Ronan M T Fleming; Ines Thiele; Jeffrey D Orth; Adam M Feist; Daniel C Zielinski; Aarash Bordbar; Nathan E Lewis; Sorena Rahmanian; Joseph Kang; Daniel R Hyduke; Bernhard Ø Palsson
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

Review 3.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 4.  Pharmacologic considerations in use and development of antituberculosis drugs.

Authors:  Geraint Davies
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-18       Impact factor: 6.915

Review 5.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

6.  Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid.

Authors:  Ashwini G Bhat; Rohit Vashisht; Nagasuma Chandra
Journal:  Syst Synth Biol       Date:  2011-02-26

7.  Construction and analysis of protein-protein interaction networks.

Authors:  Karthik Raman
Journal:  Autom Exp       Date:  2010-02-15

8.  System-level strategies for studying the metabolism of Mycobacterium tuberculosis.

Authors:  Dany J V Beste; Johnjoe McFadden
Journal:  Mol Biosyst       Date:  2010-10-11

9.  Disruption of cell wall fatty acid biosynthesis in Mycobacterium tuberculosis using a graph theoretic approach.

Authors:  Veeky Baths; Utpal Roy; Tarkeshwar Singh
Journal:  Theor Biol Med Model       Date:  2011-03-31       Impact factor: 2.432

10.  Mycobacterium tuberculosis Transcriptome Profiling in Mice with Genetically Different Susceptibility to Tuberculosis.

Authors:  T A Skvortsov; D V Ignatov; K B Majorov; A S Apt; T L Azhikina
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.